It is crucial to retain the DoCA in order to mainatin the VCR entity, otherwise the PMA will be cancelled by the FDA (applicant entity stops to exist), and the advantage of having the VentrAssist close to marketing approval in the US will be lost.
VCR
ventracor limited
new creditors meeing 3rd july, page-3
Add to My Watchlist
What is My Watchlist?